(Q36047257)

11 August 2017

Prolonged viral suppression without therapy in an HIV-1 seroconverter following early antiretroviral therapy and daily interleukin-2 (English)

1 reference

11 August 2017

1

Joseph B Margolick

1 reference

11 August 2017

6

Janet Siliciano

1 reference

11 August 2017

7

Joel Blankson

1 reference

11 August 2017

Hejab Imteyaz

2

1 reference

11 August 2017

Joel E Gallant

3

1 reference

11 August 2017

Susan J Langan

4

1 reference

11 August 2017

Jason B Dinoso

5

1 reference

11 August 2017

Tricia L Nilles

8

1 reference

11 August 2017

Kendall A Smith

9

1 reference

11 August 2017

Linda G Apuzzo

10

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

11 August 2017

1 reference

11 August 2017

24

1 reference

11 August 2017

6

1 reference

11 August 2017

932-935

1 reference

Interleukin-2 therapy in patients with HIV infection

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565498

HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565498

Immunotherapy with canarypox vaccine and interleukin-2 for HIV-1 infection: termination of a randomized trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565498

Limited durability of viral control following treated acute HIV infection

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565498

New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565498

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565498

Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565498

Effect of IL-2 therapy on CD8+ cell noncytotoxic anti-HIV response during primary HIV-1 infection

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565498

Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565498

Low-dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: a randomized controlled trial.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565498

Immune control of HIV-1 after early treatment of acute infection

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565498

Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo

5 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20234195

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Interruption of Antiretroviral Therapy Initiated during Primary HIV-1 Infection: Impact of a Therapeutic Vaccination Strategy Combined with Interleukin (IL)-2 Compared with IL-2 Alone in the ANRS 095 Randomized Study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20234195

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/QAD.0B013E328333ADFB

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

20234195

1 reference